HEG Limited has informed the Exchange about Winding Up and Discontinuation of the Medical Transcription Business of Bhilwara Infotechnology Limited, a Wholly Owned Subsidiary of the Company with effect from 1st March, 2026.
HEG · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
HEG Limited has informed the exchange that it is winding up and discontinuing the medical transcription business carried out by its wholly owned subsidiary, Bhilwara Infotechnology Limited, with effect from 1 March 2026. Bhilwara Infotechnology is a 100% subsidiary of HEG, and the medical transcription vertical was its only operating business. The move signals HEG's decision to exit this non-core segment and focus on its primary graphite electrodes business. No financial details of the wind-up cost or expected savings have been disclosed in this announcement.
This is a cleanup of a non-core subsidiary and is unlikely to materially affect HEG's earnings, which are driven by graphite electrodes. Investors should see it as a positive housekeeping step, freeing management focus and potentially removing a drag on consolidated margins, with no impact expected on share price or open offer obligations.